Home
Cambridge BioMarketing Group

Cambridge BioMarketing G... Market Share Analysis for June 2026

inizio evoke is a global health marketing, communications, and transformation platform. learn about our service areas, locations, and how to work with us.

Industry: N/A

Domaincambridgebmg.com

Year Founded2001

Employees51 - 200

Annual Revenue$15M - $25M

Cambridge BioMarketing Group

Cambridge BioMarketing Group (including company regionals)

cambridgebmg.com

See more website traffic and engagement information

Cambridge BioMarketing Group Revenue up to June 2026 is 15M - 25M

revenue generated by Cambridge BioMarketing Group top domains

Cambridge BioMarketing Group top domains revenue over 3 years

Revenue for Cambridge BioMarketing Group top domains

cambridgebmg.com15M - 25M

See more with Sales Intelligence

Total visits to Cambridge BioMarketing Group's top domains

Understand Cambridge BioMarketing Group market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Cambridge BioMarketing Group's top domains

Analyze Cambridge BioMarketing Group engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Cambridge BioMarketing Group's top domains

See how Cambridge BioMarketing Group keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Cambridge BioMarketing Group top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Cambridge BioMarketing Group

These are the website technologies, by industry, used by Cambridge BioMarketing Group top domains

Advertising (9)

DoubleClick

Widget (6)

Twemoji

Conversion & Analytics (4)

Google Analytics

Email Services (3)

Microsoft Exchange Online

More Technologies

7

See all

News & Signals from Cambridge BioMarketing Group

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCambridgebmg hired Ben Beckley as president on Sep 9th '19.Cambridge BioMarketing, an Ashfield company, part of UDG Healthcare plc and the world’s leading rare disease agency, today announced the appointment of Ben Beckley as president.

NewsFranco leaves Cambridgebmg as CEO.Franco joins the agency after eight years as CEO at Cambridge BioMarketing and a long career in the biotech industry at Genzyme.

NewsCambridgebmg launched RareID on May 14th '19.Cambridge BioMarketing, an Ashfield company, part of UDG Healthcare plc and the world’s leading rare disease agency, today announced the launch of RareID, the agency’s new, proprietary approach to identifying rare disease market solutions.